Geron Corporation to Participate in the Stifel 2026 Healthcare Conference
Globe Newswire•03/11/2026•08:00 ET
0
Key Highlights
- ➤Geron (GERN) management to participate in Stifel 2026 Healthcare Conference November 10
- ➤Fireside chat scheduled for 2:00 p.m. ET in New York
- ➤RYTELO approved in the U.S. and European Union for certain lower-risk MDS patients
FOSTER CITY, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today announced that members of the management team are scheduled to participate in a fireside chat and be available for one-on-one meetings at the Stifel 2026 Healthcare Conference on Tuesday, November 10, 2026 at 2:00 p.m. ET in New York, NY.
A live and archived audio webcast of the fireside chat will be available through the Investor section of Geron’s website at www.geron.com.
Get started
Create a free account to read the full story.